These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 31663687)

  • 21. Enzyme promiscuity: mechanism and applications.
    Hult K; Berglund P
    Trends Biotechnol; 2007 May; 25(5):231-8. PubMed ID: 17379338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Human drug metabolizing enzymes. II. Conjugation enzymes].
    Vereczkey L; Jemnitz K; Gregus Z
    Acta Pharm Hung; 1998 Sep; 68(5):284-8. PubMed ID: 9805814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stochastic ensembles, conformationally adaptive teamwork, and enzymatic detoxification.
    Atkins WM; Qian H
    Biochemistry; 2011 May; 50(19):3866-72. PubMed ID: 21473615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic polymorphisms in drug-metabolizing enzymes and drug targets.
    Hiratsuka M; Mizugaki M
    Mol Genet Metab; 2001 Aug; 73(4):298-305. PubMed ID: 11509011
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of nutritive factors on metabolic processes involving bioactivation and detoxication of chemicals.
    Guengerich FP
    Annu Rev Nutr; 1984; 4():207-31. PubMed ID: 6380537
    [No Abstract]   [Full Text] [Related]  

  • 26. Differential catalytic promiscuity of the alkaline phosphatase superfamily bimetallo core reveals mechanistic features underlying enzyme evolution.
    Sunden F; AlSadhan I; Lyubimov A; Doukov T; Swan J; Herschlag D
    J Biol Chem; 2017 Dec; 292(51):20960-20974. PubMed ID: 29070681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Drug promiscuity].
    Guo ZR
    Yao Xue Xue Bao; 2011 Apr; 46(4):361-9. PubMed ID: 21751487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of inducers on drug-metabolizing enzyme activity and on formation of reactive drug metabolites in the liver.
    Orrenius S; Thor H; Jernström B
    Ciba Found Symp; 1980; 76():25-42. PubMed ID: 6109599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of structurally divergent herbicides on mouse liver xenobiotic-metabolizing enzymes (P-450-dependent mono-oxygenases, epoxide hydrolases and glutathione S-transferases) and carnitine acetyltransferase.
    Moody DE; Narloch BA; Shull LR; Hammock BD
    Toxicol Lett; 1991 Dec; 59(1-3):175-85. PubMed ID: 1755024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of drug-metabolizing enzymes and transporters in inflammation.
    Aitken AE; Richardson TA; Morgan ET
    Annu Rev Pharmacol Toxicol; 2006; 46():123-49. PubMed ID: 16402901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How enzyme promiscuity and horizontal gene transfer contribute to metabolic innovation.
    Glasner ME; Truong DP; Morse BC
    FEBS J; 2020 Apr; 287(7):1323-1342. PubMed ID: 31858709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Catalytic Conversion of Lipophilic Substrates by Phase constrained Enzymes in the Aqueous or in the Membrane Phase.
    Cebula M; Turan IS; Sjödin B; Thulasingam M; Brock J; Chmyrov V; Widengren J; Abe H; Mannervik B; Haeggström JZ; Rinaldo-Matthis A; Akkaya EU; Morgenstern R
    Sci Rep; 2016 Dec; 6():38316. PubMed ID: 27917951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural basis for the role of mammalian aldehyde oxidases in the metabolism of drugs and xenobiotics.
    Romão MJ; Coelho C; Santos-Silva T; Foti A; Terao M; Garattini E; Leimkühler S
    Curr Opin Chem Biol; 2017 Apr; 37():39-47. PubMed ID: 28126656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aldehyde oxidase and its role as a drug metabolizing enzyme.
    Dalvie D; Di L
    Pharmacol Ther; 2019 Sep; 201():137-180. PubMed ID: 31128989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promiscuity in the Enzymatic Catalysis of Phosphate and Sulfate Transfer.
    Pabis A; Duarte F; Kamerlin SC
    Biochemistry; 2016 Jun; 55(22):3061-81. PubMed ID: 27187273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of drug-metabolizing enzymes: mechanisms and consequences.
    Okey AB; Roberts EA; Harper PA; Denison MS
    Clin Biochem; 1986 Apr; 19(2):132-41. PubMed ID: 3518989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The evolution of catalytic efficiency and substrate promiscuity in human theta class 1-1 glutathione transferase.
    Griswold KE; Aiyappan NS; Iverson BL; Georgiou G
    J Mol Biol; 2006 Dec; 364(3):400-10. PubMed ID: 17011574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein promiscuity in drug discovery, drug-repurposing and antibiotic resistance.
    Gupta MN; Alam A; Hasnain SE
    Biochimie; 2020 Aug; 175():50-57. PubMed ID: 32416199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of cytochrome P-450 and related enzymes in the pulmonary metabolism of xenobiotics.
    Philpot RM; Smith BR
    Environ Health Perspect; 1984 Apr; 55():359-67. PubMed ID: 6376107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of drug transporters on adverse drug reaction.
    Zhou Y; Zhang GQ; Wei YH; Zhang JP; Zhang GR; Ren JX; Duan HG; Rao Z; Wu XA
    Eur J Drug Metab Pharmacokinet; 2013 Jun; 38(2):77-85. PubMed ID: 23338766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.